Product Pipeline of Life Medical Sciences includes: (Based on a research report by Hancock Institutional Equity Services)
* Cariel for Wound Healing * Piliel for Hair Regrowth * Repel for Preventing Surgical Adhesions * Scar Management Device * Sure-Closure(TM) Device
About a year ago, I saw a picture by CHAI showing hair color changing from gray to black. I also saw a research report by Wedbush Morgan Security, giving a 12 month target of $20. The stock, however, only made to $11 in January, and is now under $7. This summer, the Hancock research report again give $20 as 12 month goal.
Anyone know more about the potential of this company? |